eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2020
vol. 15
 
Share:
Share:
abstract:
Review paper

Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis

Kamil Jaszczuk
1
,
Michał Lipiński
1
,
Grażyna Rydzewska
2

1.
Department of Internal Medicine and Gastroenterology with IBD Subdivision, Central Clinical Hospital of the Ministry of the Interior, Warsaw, Poland
2.
Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2020; 15 (2): 98–102
Online publish date: 2020/06/08
View full text Get citation
 
PlumX metrics:
Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), with incidence rates ranging between 2% and 16%. In addition to being experienced in endoscopic procedures and having knowledge of the patient qualification criteria, physicians should also be aware of the patient and procedure-related risk factors responsible for post-ERCP pancreatitis (PEP). Intrarectal administration of nonsteroidal anti-inflammatory drugs and pancreatic duct stenting were demonstrated to be efficient in high-risk patients. This review provides a broader summary of pharmacological methods and techniques aimed at reducing the risk of PEP.
keywords:

post-endoscopic retrograde cholangiopancreatography pancreatitis, endoscopic retrograde cholangiopancreatography, nonsteroidal anti-inflammatory drugs, pancreatic duct stents

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.